AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

TSE:HSMHelius Medical Technologies Stock Price, Forecast & News

C$0.66
+0.02 (+3.13 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.64
Now: C$0.66
C$0.66
50-Day Range
C$0.53
MA: C$0.68
C$0.95
52-Week Range
C$0.35
Now: C$0.66
C$3.11
Volume1,500 shs
Average Volume29,090 shs
Market CapitalizationC$25.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone215-944-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.03 million
Cash FlowC$0.13 per share
Book ValueC$0.14 per share

Profitability

Miscellaneous

Employees25
Market CapC$25.11 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable

Receive HSM News and Ratings via Email

Sign-up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter.

Helius Medical Technologies (TSE:HSM) Frequently Asked Questions

How has Helius Medical Technologies' stock been impacted by COVID-19 (Coronavirus)?

Helius Medical Technologies' stock was trading at C$0.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HSM stock has decreased by 5.7% and is now trading at C$0.66. View which stocks have been most impacted by Coronavirus.

When is Helius Medical Technologies' next earnings date?

Helius Medical Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Helius Medical Technologies.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies Inc (TSE:HSM) announced its quarterly earnings data on Thursday, May, 7th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.23) by $0.02. The company had revenue of $0.28 million for the quarter, compared to the consensus estimate of $0.42 million. View Helius Medical Technologies' earnings history.

Has Helius Medical Technologies been receiving favorable news coverage?

News coverage about HSM stock has been trending somewhat negative this week, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Helius Medical Technologies earned a news impact score of -1.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news about Helius Medical Technologies.

Who are some of Helius Medical Technologies' key competitors?

What other stocks do shareholders of Helius Medical Technologies own?

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:
  • Mr. Philippe Deschamps, Chairman, CEO & Pres (Age 57)
  • Ms. Joyce N. LaViscount, CFO & COO (Age 57)
  • Ms. Jennifer Laux M.B.A., Chief Commercialization Officer (Age 52)
  • Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 61)
  • Diane Carman, Sec.

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM."

How do I buy shares of Helius Medical Technologies?

Shares of HSM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Helius Medical Technologies' stock price today?

One share of HSM stock can currently be purchased for approximately C$0.66.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of C$25.11 million and generates C$1.03 million in revenue each year. Helius Medical Technologies employs 25 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is heliusmedical.com.

How can I contact Helius Medical Technologies?

The company can be reached via phone at 215-944-6100.

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.